<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35043113</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2692-8205</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2022</Year><Month>Jan</Month><Day>10</Day></PubDate></JournalIssue><Title>bioRxiv : the preprint server for biology</Title><ISOAbbreviation>bioRxiv</ISOAbbreviation></Journal><ArticleTitle>Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2022.01.07.475453</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2022.01.07.475453</ELocationID><Abstract><AbstractText>Survivors of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection frequently experience lingering neurological symptoms, including impairment in attention, concentration, speed of information processing and memory. This long-COVID cognitive syndrome shares many features with the syndrome of cancer therapy-related cognitive impairment (CRCI). Neuroinflammation, particularly microglial reactivity and consequent dysregulation of hippocampal neurogenesis and oligodendrocyte lineage cells, is central to CRCI. We hypothesized that similar cellular mechanisms may contribute to the persistent neurological symptoms associated with even mild SARS-CoV-2 respiratory infection. Here, we explored neuroinflammation caused by mild respiratory SARS-CoV-2 infection - without neuroinvasion - and effects on hippocampal neurogenesis and the oligodendroglial lineage. Using a mouse model of mild respiratory SARS-CoV-2 infection induced by intranasal SARS-CoV-2 delivery, we found white matter-selective microglial reactivity, a pattern observed in CRCI. Human brain tissue from 9 individuals with COVID-19 or SARS-CoV-2 infection exhibits the same pattern of prominent white matter-selective microglial reactivity. In mice, pro-inflammatory CSF cytokines/chemokines were elevated for at least 7-weeks post-infection; among the chemokines demonstrating persistent elevation is CCL11, which is associated with impairments in neurogenesis and cognitive function. Humans experiencing long-COVID with cognitive symptoms (48 subjects) similarly demonstrate elevated CCL11 levels compared to those with long-COVID who lack cognitive symptoms (15 subjects). Impaired hippocampal neurogenesis, decreased oligodendrocytes and myelin loss in subcortical white matter were evident at 1 week, and persisted until at least 7 weeks, following mild respiratory SARS-CoV-2 infection in mice. Taken together, the findings presented here illustrate striking similarities between neuropathophysiology after cancer therapy and after SARS-CoV-2 infection, and elucidate cellular deficits that may contribute to lasting neurological symptoms following even mild SARS-CoV-2 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Casta&#xf1;eda</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University, Stanford CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Peiwen</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale University, New Haven CT USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geraghty</LastName><ForeName>Anna C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University, Stanford CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale University, New Haven CT USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Myoung-Hwa</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>National Institute of Neurological Disorders and Stroke, Besthesda MD USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>Jamie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Abilities Research Center, Department of Rehabilitation and Human Performance, Mount Sinai School of Medicine, New York, NY USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yal&#xe7;&#x131;n</LastName><ForeName>Belgin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University, Stanford CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Kathryn R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University, Stanford CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dutton</LastName><ForeName>Selena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University, Stanford CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acosta-Alvarez</LastName><ForeName>Lehi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University, Stanford CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ni</LastName><ForeName>Lijun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University, Stanford CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras-Esquivel</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University, Stanford CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gehlhausen</LastName><ForeName>Jeff R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale University, New Haven CT USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Jon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale University, New Haven CT USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucas</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale University, New Haven CT USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Tianyang</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale University, New Haven CT USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Julio</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale University, New Haven CT USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pe&#xf1;a-Hern&#xe1;ndez</LastName><ForeName>Mario A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale University, New Haven CT USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabachnikova</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale University, New Haven CT USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Takehiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale University, New Haven CT USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabacof</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Abilities Research Center, Department of Rehabilitation and Human Performance, Mount Sinai School of Medicine, New York, NY USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tosto-Mancuso</LastName><ForeName>Jenna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Abilities Research Center, Department of Rehabilitation and Human Performance, Mount Sinai School of Medicine, New York, NY USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breyman</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Abilities Research Center, Department of Rehabilitation and Human Performance, Mount Sinai School of Medicine, New York, NY USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kontorovich</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Institute, Mount Sinai School of Medicine, New York, NY USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCarthy</LastName><ForeName>Dayna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Abilities Research Center, Department of Rehabilitation and Human Performance, Mount Sinai School of Medicine, New York, NY USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quezado</LastName><ForeName>Martha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Cancer Institute, Besthesda MD USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hefti</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Iowa, Iowa City, IA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perl</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pathology, Uniformed Services University of Health Sciences, Bethesda MD USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Folkerth</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Office of Chief Medical Examiner, New York, NY USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putrino</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Abilities Research Center, Department of Rehabilitation and Human Performance, Mount Sinai School of Medicine, New York, NY USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nath</LastName><ForeName>Avi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Institute of Neurological Disorders and Stroke, Besthesda MD USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwasaki</LastName><ForeName>Akiko</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale University, New Haven CT USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Yale University, New Haven CT USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monje</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University, Stanford CA USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Stanford University, Stanford CA USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP1 NS111132</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI157488</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS092597</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AR007016</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>bioRxiv</MedlineTA><NlmUniqueID>101680187</NlmUniqueID><ISSNLinking>2692-8205</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">cognitive impairment</Keyword><Keyword MajorTopicYN="N">hippocampal neurogenesis</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">myelin</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">oligodendrocytes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35043113</ArticleId><ArticleId IdType="pmc">PMC8764721</ArticleId><ArticleId IdType="doi">10.1101/2022.01.07.475453</ArticleId><ArticleId IdType="pii">2022.01.07.475453</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acharya M.M., Green K.N., Allen B.D., Najafi A.R., Syage A., Minasyan H., Le M.T., Kawashita T., Giedzinski E., Parihar V.K., et al. (2016). Elimination of microglia improves cognitive function following cranial irradiation. Sci Rep 6, 31545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4981848</ArticleId><ArticleId IdType="pubmed">27516055</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoub R., Ruddy R.M., Cox E., Oyefiade A., Derkach D., Laughlin S., Ades-Aron B., Shirzadi Z., Fieremans E., MacIntosh B.J., et al. (2020). Assessment of cognitive and neural recovery in survivors of pediatric brain tumors in a pilot clinical trial using metformin. Nat Med 26, 1285&#x2013;1294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8176964</ArticleId><ArticleId IdType="pubmed">32719487</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker J.H., Lin J.J., Doernberg M., Stone K., Navis A., Festa J.R., and Wisnivesky J.P. (2021). Assessment of Cognitive Function in Patients After COVID-19 Infection. JAMA Netw Open 4, e2130645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Clelland C.D., Choi M., Romberg C., Clemenson G.D. Jr., Fragniere A., Tyers P., Jessberger S., Saksida L.M., Barker R.A., Gage F.H., et al. (2009). A functional role for adult hippocampal neurogenesis in spatial pattern separation. Science 325, 210&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2997634</ArticleId><ArticleId IdType="pubmed">19590004</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., and Akrami A. (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38, 101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Funfschilling U., Supplie L., Mahad D., Boretius S., Saab A., Edgar J., Brinkmann B., Kassmann C., Tzvetanova I., Mobius W., et al. (2012). Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485, 517&#x2013;521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3613737</ArticleId><ArticleId IdType="pubmed">22622581</ArticleId></ArticleIdList></Reference><Reference><Citation>Geraghty A.C., Gibson E.M., Ghanem R.A., Greene J.J., Ocampo A., Goldstein A.K., Ni L., Yang T., Marton R.M., Pasca S.P., et al. (2019). Loss of Adaptive Myelination Contributes to Methotrexate Chemotherapy-Related Cognitive Impairment. Neuron 103, 250&#x2013;265 e258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6697075</ArticleId><ArticleId IdType="pubmed">31122677</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson E.M., and Monje M. (2021). Microglia in Cancer Therapy-Related Cognitive Impairment. Trends Neurosci 44, 441&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8593823</ArticleId><ArticleId IdType="pubmed">33674135</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson E.M., Nagaraja S., Ocampo A., Tam L.T., Wood L.S., Pallegar P.N., Greene J.J., Geraghty A.C., Goldstein A.K., Ni L., et al. (2019). Methotrexate Chemotherapy Induces Persistent Tri-glial Dysregulation that Underlies Chemotherapy-Related Cognitive Impairment. Cell 176, 43&#x2013;55 e13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6329664</ArticleId><ArticleId IdType="pubmed">30528430</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan K.A., Weigel M.K., Prakash P., Wijewardhane P.R., Hasel P., Rufen-Blanchette U., Munch A.E., Blum J.A., Fine J., Neal M.C., et al. (2021). Neurotoxic reactive astrocytes induce cell death via saturated lipids. Nature 599, 102&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">34616039</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson E.M., Purger D., Mount C.W., Goldstein A.K., Lin G.L., Wood L.S., Inema I., Miller S.E., Bieri G., Zuchero J.B., et al. (2014). Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science 344, 1252304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4096908</ArticleId><ArticleId IdType="pubmed">24727982</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond T.R., Dufort C., Dissing-Olesen L., Giera S., Young A., Wysoker A., Walker A.J., Gergits F., Segel M., Nemesh J., et al. (2019). Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes. Immunity 50, 253&#x2013;271 e256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6655561</ArticleId><ArticleId IdType="pubmed">30471926</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasel P., Rose I.V.L., Sadick J.S., Kim R.D., and Liddelow S.A. (2021). Neuroinflammatory astrocyte subtypes in the mouse brain. Nat Neurosci 24, 1475&#x2013;1487.</Citation><ArticleIdList><ArticleId IdType="pubmed">34413515</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinkle J.J., Olschowka J.A., Love T.M., Williams J.P., and O&#x2019;Banion M.K. (2019). Cranial irradiation mediated spine loss is sex-specific and complement receptor-3 dependent in male mice. Sci Rep 9, 18899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6906384</ArticleId><ArticleId IdType="pubmed">31827187</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini S., Wilk E., Michaelsen-Preusse K., Gerhauser I., Baumgartner W., Geffers R., Schughart K., and Korte M. (2018). Long-Term Neuroinflammation Induced by Influenza A Virus Infection and the Impact on Hippocampal Neuron Morphology and Function. J Neurosci 38, 3060&#x2013;3080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6596076</ArticleId><ArticleId IdType="pubmed">29487124</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelow B., Song E., Mao T., Lu P., Meir A., Liu F., Alfajaro M.M., Wei J., Dong H., Homer R.J., et al. (2020). Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling. J Exp Med 217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7401025</ArticleId><ArticleId IdType="pubmed">32750141</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.H., Perl D.P., Nair G., Li W., Maric D., Murray H., Dodd S.J., Koretsky A.P., Watts J.A., Cheung V., et al. (2021). Microvascular Injury in the Brains of Patients with Covid-19. N Engl J Med 384, 481&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Guttenplan K.A., Clarke L.E., Bennett F.C., Bohlen C.J., Schirmer L., Bennett M.L., Munch A.E., Chung W.S., Peterson T.C., et al. (2017). Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C., Wong P., Klein J., Castro T.B.R., Silva J., Sundaram M., Ellingson M.K., Mao T., Oh J.E., Israelow B., et al. (2020). Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584, 463&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., Palladini M., De Lorenzo R., Magnaghi C., Poletti S., Furlan R., Ciceri F., group C.-B.O.C.S., Rovere-Querini P., and Benedetti F. (2021). Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun 94, 138&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Miron V., Boyd A., Zhao J., Yuen T., Ruckh J., Shadrach J., van Wijngaarden P., Wagers A., Williams A., Franklin R., et al. (2013). M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 16, 1211&#x2013;1218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3977045</ArticleId><ArticleId IdType="pubmed">23872599</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M.L., Mizumatsu S., Fike J.R., and Palmer T.D. (2002). Irradiation induces neural precursor-cell dysfunction. Nat Med 8, 955&#x2013;962.</Citation><ArticleIdList><ArticleId IdType="pubmed">12161748</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M.L., Toda H., and Palmer T.D. (2003). Inflammatory blockade restores adult hippocampal neurogenesis. Science 302, 1760&#x2013;1765.</Citation><ArticleIdList><ArticleId IdType="pubmed">14615545</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M.L., Vogel H., Masek M., Ligon K.L., Fisher P.G., and Palmer T.D. (2007). Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies. Ann Neurol 62, 515&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pubmed">17786983</ArticleId></ArticleIdList></Reference><Reference><Citation>Mount C.W., and Monje M. (2017). Wrapped to Adapt: Experience-Dependent Myelination. Neuron 95, 743&#x2013;756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5667660</ArticleId><ArticleId IdType="pubmed">28817797</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., and Goodman S.N. (2021). Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review. JAMA Netw Open 4, e2111417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A. (2020). Long-Haul COVID. Neurology 95, 559&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pubmed">32788251</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A., and Smith B. (2021). Neurological issues during COVID-19: An overview. Neurosci Lett 742, 135533.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7686787</ArticleId><ArticleId IdType="pubmed">33248163</ArticleId></ArticleIdList></Reference><Reference><Citation>Noori R., Park D., Griffiths J.D., Bells S., Frankland P.W., Mabbott D., and Lefebvre J. (2020). Activity-dependent myelination: A glial mechanism of oscillatory self-organization in large-scale brain networks. Proc Natl Acad Sci U S A 117, 13227&#x2013;13237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7306810</ArticleId><ArticleId IdType="pubmed">32482855</ArticleId></ArticleIdList></Reference><Reference><Citation>Pajevic S., Basser P., and Fields R. (2014). Role of myelin plasticity in oscillations and synchrony of neuronal activity. Neuroscience 276, 135&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4037390</ArticleId><ArticleId IdType="pubmed">24291730</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandharipande P.P., Girard T.D., Jackson J.C., Morandi A., Thompson J.L., Pun B.T., Brummel N.E., Hughes C.G., Vasilevskis E.E., Shintani A.K., et al. (2013). Long-term cognitive impairment after critical illness. N Engl J Med 369, 1306&#x2013;1316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3922401</ArticleId><ArticleId IdType="pubmed">24088092</ArticleId></ArticleIdList></Reference><Reference><Citation>Remsik J., Wilcox J.A., Babady N.E., McMillen T.A., Vachha B.A., Halpern N.A., Dhawan V., Rosenblum M., Iacobuzio-Donahue C.A., Avila E.K., et al. (2021). Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients. Cancer Cell 39, 276&#x2013;283 e273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833316</ArticleId><ArticleId IdType="pubmed">33508216</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R.S., and Koles Z.J. (1970). Myelinated nerve fibers: computed effect of myelin thickness on conduction velocity. The American journal of physiology 219, 1256&#x2013;1258.</Citation><ArticleIdList><ArticleId IdType="pubmed">5473105</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Bartley C.M., Chow R.D., Ngo T.T., Jiang R., Zamecnik C.R., Dandekar R., Loudermilk R.P., Dai Y., Liu F., et al. (2021). Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. Cell Rep Med 2, 100288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8091032</ArticleId><ArticleId IdType="pubmed">33969321</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L, Tosto-Mancuso J, Wood J, Cortes M, Kontorovich A, McCarthy D, Rizk D, Rozanski G, Breyman E, Nasr L, Kellner C. et al. (2022). Post-acute COVID-19 Syndrome Negatively Impacts Physical Function, Cognitive Function, Health-Related Quality of Life, and Participation. American Journal of Physical Medicine &amp; Rehabilitation 101(1):48&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L, Tosto-Mancuso J, Wood J, Cortes M, Kontorovich A, McCarthy D, Rizk D, Mohammadi N, Breyman E, Nasr L, Kellner C. et al. (2020). Post-acute COVID-19 syndrome negatively impacts health and wellbeing despite less severe acute infection. MedRxiv.</Citation></Reference><Reference><Citation>Vasek M.J., Garber C., Dorsey D., Durrant D.M., Bollman B., Soung A., Yu J., Perez-Torres C., Frouin A., Wilton D.K., et al. (2016). A complement-microglial axis drives synapse loss during virus-induced memory impairment. Nature 534, 538&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5452615</ArticleId><ArticleId IdType="pubmed">27337340</ArticleId></ArticleIdList></Reference><Reference><Citation>Villeda S.A., Luo J., Mosher K.I., Zou B., Britschgi M., Bieri G., Stan T.M., Fainberg N., Ding Z., Eggel A., et al. (2011). The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477, 90&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170097</ArticleId><ArticleId IdType="pubmed">21886162</ArticleId></ArticleIdList></Reference><Reference><Citation>Waxman S.G. (1980). Determinants of conduction velocity in myelinated nerve fibers. Muscle Nerve 3, 141&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">6245357</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang A.C., Kern F., Losada P.M., Agam M.R., Maat C.A., Schmartz G.P., Fehlmann T., Stein J.A., Schaum N., Lee D.P., et al. (2021). Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature 595, 565&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C.L., Zou Y., He W., Gage F.H., and Evans R.M. (2008). A role for adult TLX-positive neural stem cells in learning and behaviour. Nature 451, 1004&#x2013;1007.</Citation><ArticleIdList><ArticleId IdType="pubmed">18235445</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>